MRKR - Marker Therapeutics Inc logo

MRKR

Marker Therapeutics Inc

Rev โ€”top 1%10Y
Hold

Marker Therapeutics develops T cell-based immunotherapies for hematological malignancies and solid tumors, utilizing multi antigen recognizing technology to target tumor-associated antigens. Key products include MT-601 and MT-401-OTS in clinical trials.

โš•๏ธ Healthcare NASDAQ Listed 2014 $ USD
$1,000 invested 20 years ago โ†’$0today

Score Overview

1 Year
Score
Net Growth-13.35%
Net TrendShrank
Net Income Consistencyโ€”
Rev Growth-46.19%
Rev TrendShrank
Revenue Consistencyโ€”
5 Years
Score5.3
Net Growth57.63%
Net Trend40%
Net Income Consistencyโ€”
Rev Growth7x
Rev Trend60%
Revenue Consistencyโ€”
10 Years
Scoreโ€”
Net Growth64.29%
Net Trend40%
Net Income Consistency
Rev Growthโ€”
Rev Trend70%
Revenue Consistency
All Time
Scoreโ€”
Net Growth60.61%
Net Trend36%
Net Income Consistency
Rev Growthโ€”
Rev Trend64%
Revenue Consistency

See the full market ranking โ†’

Marker Therapeutics Inc fundamental performance

Between 2020 and 2025, revenue grew from $ 466.79K to $ 3M and net income went from -$ 28M to -$ 12M. Revenue increased in 3 of those 5 years; net income in 2.

Marker Therapeutics Inc currently holds a 5-year HDB Score of 5.3 out of 10. How the HDB Score is calculated.

Net Income x Stock Price

Historical Returns

Historical Returns
PeriodPriceReturn
Last Price2026-08-12
$ 1.16โ€”
1 Year2025-08-12
$ 1.28-9.38%
5 Years2021-08-12
$ 19.80-94.14%
10 Years2016-08-12
$ 63.60-98.18%
20 Years2006-08-11
$ 33K-100.00%
All Time2014-03-25
$ 582.00-99.80%

Prices are split & dividend adjusted. All values are reported in USD.

Fundamental Data

Year
2025$ 3M-$ 12M$ 16.06T
2024$ 6M-$ 10M$ 19M
2023$ 3M-$ 8M$ 15M
2022$ 3M-$ 29M$ 11M
2021$ 1M-$ 41M$ 42M
2020$ 466.79K-$ 28M$ 21M
2019$ 213.19K-$ 21M$ 43M
2018$ 205.99K-$ 147M$ 61M
2017$ 183.06K-$ 10M$ 5M
2016$ 0.00-$ 2M$ 7M
2015$ 0.00-$ 34M$ 6M
IPO2014$ 0.00-$ 30M$ 141.94K

Explore beyond MRKR

You're looking at Marker Therapeutics Inc. Members apply the same fundamental framework across all 3,860 companies we cover.

$99/year $149 founding price

Unlock Holder Dashboard

30-day money-back guarantee.

Explore other companies